Sanofi said the study results show the hemophilia A treatment met its primary endpoint with no inhibitor development to factor VIII detected.
‘Portraits of Progress’ will run in New York through the end of this week before touring the country and Europe later this year.
Sanofi to buy Bioverativ for $11.6 billion; Celgene to acquire Juno for $9 billion; Teva to lay off more than 200 in Philadelphia
MM+M is proud to announce the fourth annual Pinnacle Awards program, which celebrates the medical marketing industry’s most venerable marketers, strategists and creators.
Get the most out of
Register for free and enjoy unlimited access to:
